CRVS · Corvus Pharmaceuticals, Inc.
$14.10
-0.80 (-5.37%)
At close · Jul 20
Market Cap
$1.19B
Shares
84.09M
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
76/100
Short interest 22.4% of shares — P99
Days to cover 12.4 — P96
Price vs VWAP +1.5% — P65
Short-volume trend -2.4% — P42
Short interest change +5.2% — P59
Worst FTD 0.02% of shares — P48
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 18,819,891 | 17,882,834 | +937,057 | 12.38 |
| 2026-06-15 | 17,882,834 | 17,324,311 | +558,523 | 14.37 |
| 2026-05-29 | 17,324,311 | 18,910,283 | -1,585,972 | 8.45 |
| 2026-05-15 | 18,910,283 | 18,385,941 | +524,342 | 11.98 |
| 2026-04-30 | 18,385,941 | 16,928,111 | +1,457,830 | 11.54 |
| 2026-04-15 | 16,928,111 | 16,951,894 | -23,783 | 21.77 |
| 2026-03-31 | 16,951,894 | 16,054,916 | +896,978 | 11.09 |
| 2026-03-13 | 16,054,916 | 16,009,857 | +45,059 | 14.71 |
| 2026-02-27 | 16,009,857 | 14,883,150 | +1,126,707 | 13.29 |
| 2026-02-13 | 14,883,150 | 14,678,521 | +204,629 | 9.81 |
| 2026-01-30 | 14,678,521 | 11,486,255 | +3,192,266 | 1.09 |
| 2026-01-15 | 11,486,255 | 11,816,663 | -330,408 | 7.54 |
| 2025-12-31 | 11,816,663 | 9,383,518 | +2,433,145 | 6.47 |
| 2025-12-15 | 9,383,518 | 9,812,924 | -429,406 | 6.71 |
| 2025-11-28 | 9,812,924 | 9,902,822 | -89,898 | 12.97 |
| 2025-11-14 | 9,902,822 | 9,028,415 | +874,407 | 8.72 |
| 2025-10-31 | 9,028,415 | 8,833,502 | +194,913 | 8.88 |
| 2025-10-15 | 8,833,502 | 10,096,570 | -1,263,068 | 7.85 |
| 2025-09-30 | 10,096,570 | 9,670,508 | +426,062 | 12.64 |
| 2025-09-15 | 9,670,508 | 9,593,924 | +76,584 | 15.37 |
| 2025-08-29 | 9,593,924 | 9,294,023 | +299,901 | 17.60 |
| 2025-08-15 | 9,294,023 | 8,792,759 | +501,264 | 18.81 |
| 2025-07-31 | 8,792,759 | 8,984,611 | -191,852 | 19.79 |
Showing 1–23 of 23 settlements
Key facts
CIK
1626971
CUSIP
221015100
13F (30d)
10 filings
10 filers
Visit website
Investor relations